The present disclosure provides methods of treating an alloimmune or autoimmune disorder in an individual； the methods involve administering to the individual an effective amount of an antibody specific for complement component C1s. The present disclosure provides a method of monitoring the efficacy of a subject treatment method； the method involves detecting the level of autoantibody or alloantibody in a biological sample obtained from the individual.
